DVA

#789
DaVita Inc. Common Stock
196.0 0 USD
-0.58%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
196.00
197.06
年范围
101.00
202.58
日变化
-0.58%
每月变动
+29.87%
6个月变化
+64.33%
年变化
+44.56%
前一天收盘价
197.1 4
Open
197.0 6
最低价
196.0 0
High
197.0 6
交易量
33
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 12.58 B
  • Employee 78 K
  • Founded 1992
  • CEO Javier J. Rodriguez
  • Website www.davita.com
  • Headquarter Delaware, United States
  • FIGI BBG000MQ1SN9
  • Industry 医疗保健设施
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
11.55
市销率
0.63

DaVita Inc. Common Stock

DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.

新闻